Millipore Sigma Vibrant Logo

03-198 RIPAb+™ IGF2 mRNA-binding protein 3 - RIP Validated Antibody and Primer Set

View Products on Sigmaaldrich.com
03-198
10 assays  10 assays per set. Recommended use: ~5 μg of antibody per RIP (dependent upon biological context).
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
Demander le prix
Disponibilité limitée
Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

      Offres spéciales

       

      Contacter le Service Clients

      Aperçu

      Replacement Information

      Offres spéciales

      Tableau de caractéristiques principal

      Species ReactivityKey Applications
      H, M, Chp, Ca, EqRIP, WB, IP
      Description
      Catalogue Number03-198
      Trade Name
      • RIPAb+
      • Upstate
      DescriptionRIPAb+™ IGF2 mRNA-binding protein 3 - RIP Validated Antibody and Primer Set
      OverviewRIPAb+ antibodies are evaluated using the RNA Binding Protein Immunoprecipitation (RIP) assay. Each RIPAb+ antibody set includes a negative control antibody to ensure specificity of the RIP reaction and is verified for the co-immunoprecipitation of RNA associated specifically with the immunoprecipitated RNA binding protein of interest. Where appropriate, the RIPAb+ set also includes quantitative RT-PCR control primers (RIP Primers) to biologically validate your IP results by successfully co-precipitating the specific RNA targets, such as messenger RNAs. The qPCR protocol and primer sequences are provided, allowing researchers to validate RIP protocols when using the antibody in their experimental context. If a target specific assay is not provided, the RIPAb+ kit is validated using an automated microfluidics-based assay by enrichment of detectable RNA over control immunoprecipitation.
      IGF2 mRNA-binding protein 3 contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism.
      Alternate Names
      • IGF II mRNA binding protein 3
      • IGF-II mRNA-binding protein 3
      • IGF2 mRNA-binding protein 3
      • KH domain containing protein overexpressed in cancer
      • KH domain-containing protein overexpressed in cancer
      • VICKZ family member 3
      • insulin-like growth factor 2 mRNA binding protein 3
      Background InformationThe protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor 2 leader 3 mRNA and may repress translation of insulin-like growth factor 2 during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism. A pseudogene exists on chromosome 7, and there are putative pseudogenes on other chromosomes. [provided by RefSeq].
      References
      Product Information
      FormatAffinity Purified
      Control
      • Includes negative control normal rabbit IgG antibody and control primers specific for the cDNA of human IGF2.
      PresentationAnti-IGF2 mRNA-binding protein 3 (Rabbit Polyclonal). One vial containing 75 μL of affinity purified rabbit polyclonal antibody in PBS with 0.09% sodium azide and 30% glycerol. Store at -20°C. Concentration: 0.7 mg/mL
      Normal Rabbit IgG. One vial containing 125 μg of rabbit IgG in 125 μL of storage buffer containing 0.05% sodium azide. Store at -20°C.
      RIP Primer IGF2, Part # CS207311.
      One vial containing 75 μL of 5 μM of each primer specific for human IGF2 mRNA. Store at -20°C.
      FOR: GCG GCT TCT ACT TCA GCA G
      REV: CAG GTG TCA TAT TGG AAG AAC
      Quality LevelMQ100
      Applications
      ApplicationThis RIPAb+ IGF2 mRNA-binding protein 3 -RIP Validated Antibody & Primer Set conveniently includes the antibody & the specific control PCR primers.
      Key Applications
      • RNA Binding Protein Immunoprecipitation (RIP)
      • Western Blotting
      • Immunoprecipitation
      Application NotesImmunoprecipitation from RIP lysate:
      Representative lot data.
      RIP lysate from HeLa cells (~2 X 10E7 cell equivalents per IP) was subjected to immunoprecipitation using 5 µg of either a normal Rabbit IgG, (Cat. # PP64B), or 5 µg of Anti-IGF2 mRNA-binding protein 3 antibody (Cat. # CS207310). Ten percent of the precipitated proteins (lane 1: Rabbit IgG, lane 2: IGF2 mRNA-binding protein 3) were resolved by electrophoresis, transferred to nitrocellulose and probed with anti-IGF2 mRNA-binding protein 3 antibody (Cat. # CS207310, 1:1000). Proteins were visualized using One-Step™ IP-Western kit (GenScript Cat. # L00231) Arrow indicates IGF2 mRNA-binding protein 3. The lower band in lane 2 correspond to the isoform 2.
      Western Blot Analysis:
      Representative lot data.
      HEK293 cell lysate was resolved by electrophoresis, transferred to PVDF membranes and probed with IGF2BP3, (1:2,000) dilution. Proteins were visualized using a Donkey anti-Rabbit conjugated to HRP using a chemiluminescence detection system.
      Arrow indicates IGF2BP3 (~64 kDa).
      Biological Information
      ImmunogenKLH-conjugated linear peptide corresponding to human IGF2 mRNA-binding protein 3 at and around the C-terminus.
      EpitopeC-terminus
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostRabbit
      SpecificityThis antibody recognizes IGF2 mRNA-binding protein 3 at the C-terminus.
      Species Reactivity
      • Human
      • Mouse
      • Chimpanzee
      • Canine
      • Horse
      Species Reactivity NoteReacts with human and mouse. Predicted to react with chimpanzee, Rhesus monkey, dog, and horse based on 100% sequence homology.
      Antibody TypePolyclonal Antibody
      Entrez Gene Number
      Entrez Gene SummaryThe protein encoded by this gene is primarily found in the nucleolus, where it can bind to the 5' UTR of the insulin-like growth factor 2 leader 3 mRNA and may repress translation of insulin-like growth factor 2 during late development. The encoded protein contains several KH domains, which are important in RNA binding and are known to be involved in RNA synthesis and metabolism. A pseudogene exists on chromosome 7, and there are putative pseudogenes on other chromosomes. [provided by RefSeq].
      Gene Symbol
      • IMP-3
      • IMP3
      • KOC1
      • VICKZ3
      • hKOC
      • IGF2BP3
      Purification MethodAffinity Purfied
      UniProt Number
      UniProt SummaryFUNCTION: RNA-binding protein that act as a regulator of mRNA translation and stability. Binds to the 5'-UTR of the insulin-like growth factor 2 (IGF2) mRNAs. Binds to sequences in the 3'-UTR of CD44 mRNA.

      SUBUNIT STRUCTURE: Homodimer and multimer.

      SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note: Found in lamellipodia of the leading edge, in the perinuclear region, and beneath the plasma membrane. The subcytoplasmic localization is cell specific and regulated by cell contact and growth. Localized at the connecting piece and the tail of the spermatozoa. Colocalized with CD44 mRNA in RNP granules.

      TISSUE SPECIFICITY: Expressed in fetal liver, fetal lung, fetal kidney, fetal thymus, fetal placenta, fetal follicles of ovary and gonocytes of testis, growing oocytes, spermatogonia and semen (at protein level). Expressed in cervix adenocarcinoma, in testicular, pancreatic and renal-cell carcinomas (at protein level). Expressed ubiquitously during fetal development at 8 and 14 weeks of gestation. Expressed in ovary, testis, brain, placenta, pancreatic cancer tissues and pancreatic cancer cell lines.

      INVOLVEMENT IN DISEASE: Autoantibodies against IGF2BP3 are detected in sera from some patients with a variety of carcinomas.

      SEQUENCE SIMILARITIES: Belongs to the RRM IMP/VICKZ family.

      Contains 4 KH domains.

      Contains 2 RRM (RNA recognition motif) domains.
      Molecular Weight64 kDa was observed. Predicted to cross-react with all the Isoforms of IGF2BP3.
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceRNA Binding Protein Immunoprecipitation:
      Representative lot data.
      RIP Lysate prepared from HepG2 cells (2 X 10E7 cell equivalents per IP) were subjected to immunoprecipitation using 5 µg of either a normal Rabbit IgG or 5 µg of Anti-IGF2 mRNA-binding protein antibody and the Magna RIP™ RNA-Binding Protein Immunoprecipitation Kit (Cat. # 17-700).
      Successful immunoprecipitation of IGF2 mRNA-binding protein 3-associated RNA was verified by qPCR using RIP Primers IGF2, (Figure 1).
      Please refer to the Magna RIP™ (Cat. # 17-700) or EZ-Magna RIP™ (Cat. # 17-701) protocol for experimental details.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt.
      Handling Recommendations: Upon receipt, and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance. Note: Variabillity in freezer temperatures below -20°C may cause glycerol containing solutions to become frozen during storage.
      Packaging Information
      Material Size10 assays
      Material Package10 assays per set. Recommended use: ~5 μg of antibody per RIP (dependent upon biological context).
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      03-198 04053252527111

      Documentation

      RIPAb+™ IGF2 mRNA-binding protein 3 - RIP Validated Antibody and Primer Set FDS

      Titre

      Fiche de données de sécurité des matériaux (FDS) 

      RIPAb+™ IGF2 mRNA-binding protein 3 - RIP Validated Antibody and Primer Set Certificats d'analyse

      TitreNuméro de lot
      RIPAb+ IGF2 mRNA-binding protein 3 - 2140075 2140075
      RIPAb+ IGF2 mRNA-binding protein 3 - NRG1860682 NRG1860682
      RIPAb+™ IGF2 mRNA-binding protein -2784013 2784013
      RIPAb+™ IGF2 mRNA-binding protein -2792364 2792364
      RIPAb+™ IGF2 mRNA-binding protein 3 2476813
      RIPAb+™ IGF2 mRNA-binding protein 3 - 3201961 3201961
      RIPAb+™ IGF2 mRNA-binding protein 3 - 3449721 3449721
      RIPAb+™ IGF2 mRNA-binding protein 3 - 3474348 3474348
      RIPAb+™ IGF2 mRNA-binding protein 3 - 3526397 3526397
      RIPAb+™ IGF2 mRNA-binding protein 3 - 3752098 3752098

      Brochure

      Titre
      New Products: Volume 3, 2012

      Produits & Applications associés

      Related Products

      Référence Description  
      07-104 Anti-IGF2 mRNA-binding protein 3 Antibody Prix & Disponibilité

      Produits associés classés par : Brand Facete

      Catégories

      Life Science Research > Antibodies and Assays > Immunoassays > Immunoprecipitation (IP) > RNA-Binding Protein Immunoprecipitation (RIP) > RIP Validated Antibodies
      Life Science Research > Antibodies and Assays > Primary Antibodies
      Life Science Research > Protein Detection and Quantification > Immunoassays > Immunoprecipitation (IP) > RNA-Binding Protein Immunoprecipitation (RIP) > RIP Validated Antibodies